Suche

Programmdetails

Freie Vortragssitzungen

Transkatheter AV-Klappentherapie: Prognose

Donnerstag, 4. April | 16:00 - 17:30 Uhr | Clinical Science Box 1

Vorsitz/Chair: Peter Lüdike (Osnabrück), Holger Nef (Bad Segeberg)

Agenda

16:00
(V1037)
Etiology of mitral regurgitation setting the course in long-term survival after successful Transcatheter Edge-to-Edge Repair
F. Ausbüttel (Marburg)
16:07
Diskussion
16:11
(V1038)
Behandlung der Mitralklappeninsuffizienz mittels kathetergestützter Edge-to-Edge-Therapie (TEER) an einer kommunalen Klinik ohne Herzchirurgie
A. Mehlig (Memmingen)
16:18
Diskussion
16:22
(V1039)
The impact of recurrent mitral regurgitation following transcatheter mitral edge-to-edge repair on long-term outcomes
C. Pauschinger (Hamburg)
16:29
Diskussion
16:33
(V1040)
Long-term mortality after transcatheter Edge-to-Edge Mitral Valve repair significantly decreased over the last decade: comparison between initial and current experience from the MitraUlm Registry
N. Nita (Ulm)
16:40
Diskussion
16:44
(V1041)
5-year outcomes following Valve-in-Ring and Valve-in-Valve procedures for failing mitral annuloplasty rings and bioprosthetic valves
A. Schäfer (Hamburg)
16:51
Diskussion
16:55
(V1042)
Outcomes of Transcatheter Edge-to-Edge Repair in Patients with Degenerative Mitral Regurgitation Presenting with NYHA Class IV Symptoms: Insights from the Global PRIME-MR Registry
B. Köll (Hamburg)
17:02
Diskussion
17:06
(V1043)
One-year outcomes of screen failure patients who were evaluated for transcatheter tricuspid valve repair: Insights from the TriSelect-Study
M. Gercek (Bad Oeynhausen)
17:13
Diskussion
17:17
(V1044)
Efficacy and Safety of Direct Annuloplasty in CIED Patients with Tricuspid Regurgitation: real-world insights
J. Wrobel (Köln)
17:24
Diskussion
17:45 - 19:45

Eröffnung des Kongresses in Saal 4

Diese Seite teilen